Company Filing History:
Years Active: 2016
Title: Thomas Winkler: Innovator in Human Cytomegalovirus Treatment
Introduction
Thomas Winkler is a notable inventor based in Erlangen, Germany. He has made significant contributions to the field of medical research, particularly in the area of human cytomegalovirus (hCMV) treatment. His innovative work has the potential to impact the lives of many individuals affected by this virus.
Latest Patents
Winkler holds a patent for "Binding members for human cytomegalovirus." This invention relates to binding members, especially antibody molecules, that can neutralize the biological effects of hCMV. The binding members developed by Winkler may be useful for both the treatment and prophylaxis of hCMV infection. He has 1 patent to his name, showcasing his dedication to advancing medical science.
Career Highlights
Thomas Winkler is currently associated with 4-Antibody AG, a company focused on developing therapeutic antibodies. His work at the company emphasizes the importance of innovative solutions in combating viral infections. Winkler's expertise and research have positioned him as a key figure in the field of virology.
Collaborations
Winkler has collaborated with notable colleagues, including Ulf Grawunder and Michael Mach. These partnerships highlight the collaborative nature of scientific research and the importance of teamwork in achieving groundbreaking results.
Conclusion
In summary, Thomas Winkler is an influential inventor whose work on binding members for human cytomegalovirus has the potential to transform treatment options for patients. His contributions to the field of medical research are commendable and reflect his commitment to innovation.